Polus

Korean, Early-stage Biopharma company developing biosimilars to existing therapeutics

placeSeoul, Seoul, South Korea calendar_todayFounded 2015 language polus-global.com

Registered entities

Innovation

4 patent families — focus: Chemistry & metallurgy, Operations & transport; filing pace slowing. Cited 108 times.

YearFilings
20204
20214
20223
20231

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon